Joha Rice

• 24 Jun 2023

Recently, the Institute of Advanced Study in Science and Technology (IASST), an autonomous institute under the Department of Science and Technology in India, undertook a research study to investigate the nutraceutical properties of Joha rice.

• About Joha Rice: Joha rice is an aromatic rice variety grown in the Northeastern region of India and is believed to have potential health benefits, particularly in the management of diabetes.

Key Findings of the Study

• Presence of Essential Fatty Acids: The research identified the presence of two essential fatty acids, linoleic acid (omega-6) and linolenic acid (omega-3), in Joha rice.
• These fatty acids are crucial for maintaining various physiological functions and have been associated with the prevention of metabolic diseases like diabetes, cardiovascular diseases, and cancer.
• Balanced Ratio of Omega-6 to Omega-3: Scented Joha rice exhibited a more balanced ratio of omega-6 to omega-3 fatty acids compared to non-scented rice varieties.
• A balanced ratio of these fatty acids is important for maintaining optimal health, and Joha rice's composition suggests its potential to contribute to a balanced diet and aid in diabetes management.
• Antioxidant-Rich Composition: Joha rice was found to be rich in antioxidants, flavonoids, and phenolics. Bioactive compounds such as oryzanol, ferulic acid, tocotrienol, caffeic acid, catechuic acid, gallic acid, and tricin were identified in Joha rice.
• These compounds possess antioxidant properties and have been associated with hypoglycemic and cardio-protective effects.
• Potential Diabetes Management: The study revealed that Joha rice demonstrated effectiveness in lowering blood glucose levels and preventing the onset of diabetes in diabetic rats.
• This suggests the potential of Joha rice as a nutraceutical for diabetes management.
• Traditional Claims Validation: The research aimed to scientifically validate the traditional claims that consumers of Joha rice have a lower incidence of diabetes and cardiovascular diseases.
• While the study provided preliminary evidence supporting these claims, further research, including human trials, would be necessary for conclusive validation.